Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors

Cancer Research

Volumn 66, Issue 21, 2006, Pages 10621-10629

  Marsit, Carmen J ^a   Houseman, E Andres ^a   Christensen, Brock C ^a   Eddy, Karen ^a   Bueno, Raphael ^a   Sugarbaker, David J ^a   Nelson, Heather H ^a   Karagas, Margaret R ^b   Kelsey, Karl T ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CONTROLLED STUDY; CPG ISLAND; HEAD AND NECK CARCINOMA; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; METHYLATION; MUTATION; PHENOTYPE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; HEAD AND NECK NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASMS; NUCLEAR PROTEINS; PHENOTYPE; PROMOTER REGIONS (GENETICS); URINARY BLADDER NEOPLASMS;

EID: 33751275546     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1687     Document Type: Article

References (43)

1. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006;7:21-33.
2. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
3. Li Q, Jedlicka A, Ahuja N, et al. Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene 1998;16:3197-202.
4. Abe M, Ohira M, Kaneda A, et al. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res 2005;65:828-34.
5. Toyota M, Ahuja N, Suzuki H, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999;59:5438-42.
6. Shen L, Ahuja N, Shen Y, et al. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002;94:755-61.
7. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol 2005;23:7043-9.
8. Chan AO, Kim SG, Bedeir A, Issa JP, Hamilton SR, Rashid A. CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 2003;22:924-34.
9. Strathdee G, Appleton K, Illand M, et al. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol 2001;158:1121-7.
10. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-93.
11. Anacleto C, Leopoldino AM, Rossi B, et al. Colorectal cancer "methylator phenotype": fact or artifact? Neoplasia 2005;7:331-5.
12. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999;91:2032-8.
13. Marsit CJ, Karagas MR, Andrew A, et al. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 2005;65:7081-5.
14. Kraunz KS, Nelson HH, Lemos M, Godleski JJ, Wiencke JK, Kelsey KT. Homozygous deletion of p16(INK4a) and tobacco carcinogen exposure in non-small cell lung cancer. Int J Cancer 2006;118:1364-9.
15. Hirao T, Bueno R, Chen CJ, Gordon GJ, Heilig E, Kelsey KT. Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Carcinogenesis 2002;23:1127-30.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
17. van Engeland M, Roemen GM, Brink M, et al. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 2002;21:3792-5.
18. Virmani AK, Rathi A, Sathyanarayana UG, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res 2001;7:1998-2004.
19. Virmani A, Rathi A, Sugio K, et al. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer 2003;106:198-204.
20. Sathyanarayana UG, Maruyama R, Padar A, et al. Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes. Cancer Res 2004;64:1425-30.
21. Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004;36:417-22.
22. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001;61:249-55.
23. Toyooka S, Pass HI, Shivapurkar N, et al. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res 2001;61:5727-30.
24. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002;160:1823-30.
25. Lee S, Kim WH, Jung HY, Yang MH, Kang GH. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am J Pathol 2002;161:1015-22.
26. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
27. Sathyanarayana UG, Moore AY, Li L, et al. Sun exposure related methylation in malignant and non-malignant skin lesions. Cancer Lett. Epub 2006 Feb 20.
28. Team RDC. R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing 2005.
29. Bartholomew DJ. Latent variable models and factor analysis. London: Charles Griffin & Co. Ltd.; 1987. p. x, 193 p.
30. Bandeen-Roche K, Miglioretti DL, Zeger SL, Rauthouz PJ. Latent variable regression for multiple discrete outcomes. J Am Stat Assoc 1997;92:1375-86.
31. Lindsay B, Clogg CC, Grego J. Semiparametric estimation in the Rasch model and related exponential response models, including simple latent class model for item analysis. J Am Stat Assoc 1991;86:96-107.
32. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer-Verlag; 2001. p. 214-7.
33. Ripley B. tree: classification and regression trees. R package version 1.0-19. edition 2005.
34. Agresti A. 7.1 Nominal responses: baseline-category logit models. In: Categorical data analysis. 2nd ed. Hoboken (NJ): John Wiley & Sons; 2002. p. 267-72.
35. Hastie T, Tibshirani R, Friedman JH. The elements of statistical learning: data mining, inference, and prediction. New York Springer; 2001. p. xvi, 533 p.
36. Houseman FA Coull BA, Betensky RA. Feature-specific penalized latent class analysis for genomic data. Biometrics. In press 2006.
37. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr AC 1974;18: 716-23.
38. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
39. Marsit CJ, Karagas MR, Danaee H, et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 2006;27:112-6.
40. Toyooka S, Tokumo M, Shigematsu H, et al. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 2006;66:1371-5.
41. Toyota M, Issa JP. CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 1999;9:349-57.
42. Kim DH, Nelson HH, Wiencke JK, et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001;61:3419-24.
43. Kraunz KS, Hsiung D, McClean MD, et al. Dietary folate is associated with p16ink4a methylation in head and neck squamous cell carcinoma. Int J Cancer 2006;119:1553-7.